Viscardia
Manufacturing · Oregon, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
8770 SW Nimbus Ave Ste D, Beaverton, Ore...Phone Number
(503) 431-3820Website
www.viscardia.comRevenue
<$5 MillionIndustry
About Viscardia
VisCardia has developed an innovative implantable device therapy aimed at treating heart failure, particularly for patients with reduced ejection fraction and preserved ventricular synchrony. The company addresses the health economic burden posed by heart failure, affecting millions and resulting in significant healthcare costs. VisCardia's minimally-invasive therapy offers an alternative to those whose only options have been complicated surgical procedures or inadequate drugs. The company's initial clinical studies have been concluded in Europe, with results expected to be presented at major cardiology scientific meetings.Explore more
Viscardia Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Viscardia
Compare insights from companies similar to Viscardia, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Viscardia Tech Stack
A closer look at the technologies used by Viscardia
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Viscardia
Sign Up For FreeTo access detailed company insights
VisCardia has developed an innovative implantable device therapy aimed at treating heart failure, particularly for patients with reduced ejection fraction and preserved ventricular synchrony. The company addresses the health economic burden posed by heart failure, affecting millions and resulting in significant healthcare costs. VisCardia's minimal... Read More
